Arsenal Capital Management

InterShunt, founded in 2015 and based in St Louis, Missouri, specializes in designing and developing a catheter-based minimally-invasive procedure aimed at alleviating symptoms for individuals suffering from heart failure. The company focuses on left atrial decompression as a key solution to reduce these symptoms. Their proprietary system involves an interatrial shunting device that does not require an implant or energy source, allowing doctors to lower left atrial pressure in patients with heart failure through a simple catheter procedure.

Juristat is a company that specializes in transforming public patent data into actionable analytics to enhance patent prosecution strategies for law firms and in-house counsel. Its platform employs a proprietary natural language processing algorithm to organize and analyze data from the United States Patent and Trademark Office. One of its key offerings, the Examiner Report, evaluates the past behaviors of patent examiners to predict future actions, enabling users to improve allowance rates, shorten time to allowance, and minimize costs by avoiding ineffective strategies, especially in response to adverse office actions. Juristat's extensive database includes detailed records for over 5.5 million patent applications, covering 99% of active art units and examiners. The platform allows users to filter results by various metrics, including individual examiners and application types, while also tracking behavioral changes over time.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Deck Commerce is a developer of a cloud-based order management platform aimed at enhancing e-commerce operations for retailers. The platform addresses common challenges in data management, system integration, and business processes faced by e-commerce businesses. It provides features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small to mid-sized e-commerce businesses to efficiently manage their orders, inventory, and product data while leveraging their existing systems. This streamlined approach allows retailers to operate more effectively in a competitive retail environment.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Aptimmune is a biotechnology company headquartered in St. Louis, Missouri, established in 2010. It specializes in the development of mucosal vaccines aimed at preventing viral diseases in swine, specifically targeting the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. By employing innovative technologies, including a proprietary pig alveolar macrophage cell line known as ZMAC, Aptimmune creates effective nasal delivery vaccines that provide lasting immune responses and enhance disease protection for animal breeders.

Deck Commerce is a developer of a cloud-based order management platform aimed at enhancing e-commerce operations for retailers. The platform addresses common challenges in data management, system integration, and business processes faced by e-commerce businesses. It provides features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small to mid-sized e-commerce businesses to efficiently manage their orders, inventory, and product data while leveraging their existing systems. This streamlined approach allows retailers to operate more effectively in a competitive retail environment.

PowerPublish is a virtual newsroom that offers a content publishing platform designed to curate, create, and disseminate premium content for modern brands. By leveraging technology and content automation, PowerPublish enables companies to transform into effective publishers, enhancing their ability to share their voice and establish search authority. The platform facilitates the intelligent and valuable publication of content across various social media channels while also monitoring marketing performance. This comprehensive approach allows businesses to effectively monetize their content and expertise, ensuring a seamless experience in content distribution and audience engagement.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on enhancing workplace culture by providing tools for employee recognition, communications, feedback, and event management. Its technology aims to reshape the employee experience through mobile-first, real-time communication features, such as announcements, targeted broadcasts, and pop surveys. By fostering camaraderie and aligning organizational culture, Bonfyre helps enterprises increase employee engagement and build collaborative, innovative environments.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on enhancing workplace culture by providing tools for employee recognition, communications, feedback, and event management. Its technology aims to reshape the employee experience through mobile-first, real-time communication features, such as announcements, targeted broadcasts, and pop surveys. By fostering camaraderie and aligning organizational culture, Bonfyre helps enterprises increase employee engagement and build collaborative, innovative environments.

Harbor MedTech, Inc. is a regenerative medicine company based in Irvine, California, that focuses on developing and commercializing tissue regeneration products. Founded in 2010, the company offers a range of innovative solutions including Architect, an extracellular collagen matrix designed for managing various types of wounds such as diabetic ulcers and surgical wounds, and EPMatrix, a collagen scaffold for soft tissue repair. Harbor MedTech's product pipeline leverages its BriDGE platform to create advanced therapies for applications in breast reconstruction, hernia repair, and orthopedic repairs, including Achilles tendon and rotator cuff repairs. Additionally, the company provides NeuvoCell, a wound therapy specifically targeting chronic wounds. Through its strategic partnerships, Harbor MedTech aims to enhance patient outcomes by utilizing its technology to activate and support the body's natural healing processes.

Synek created the SYNEK beer dispenser and personally thanked every backer by taking a 42-city RV tour to deliver the 2,500 pre-ordered dispensers. The SYNEK beer dispenser refrigerates, pressurizes, and dispenses beer in the coolest way possible—brewery-quality beer, fresh on draft, in your home.

Wellopp is a company that specializes in social health intelligence, focusing on chronic care management. Its platform utilizes data from various social health determinants to engage patients and provide personalized experiences throughout their healthcare journey. By emphasizing behavioral change and leveraging innovative social health technologies, Wellopp aims to enhance the quality of care while managing costs effectively. The company's solutions are designed to address the significant issue of preventable hospital readmissions, which contribute to substantial financial losses in the U.S. healthcare system. Through its approach, Wellopp empowers healthcare providers to improve patient outcomes and reduce readmission rates, all while ensuring compliance with privacy regulations such as HIPAA.

KEW, Inc., established in 2009 and headquartered in Cambridge, Massachusetts, specializes in genomic testing services for cancer patients. The company's core offering, CANCERPLEX, is a precision medicine service that analyzes a patient's genetic drivers to help oncologists select personalized, targeted therapies. KEW's suite of products includes CANCERPLEX FP, a full panel test with immunotherapy options, CANCERPLEX TS for common tumor sites, and CANCERPLEX TX for FDA-approved targeted therapies. The company delivers these solutions through strategic partnerships and distributors, enabling evidence-driven treatment decisions in cancer care.

Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

TransMed Systems, Inc. is a software development company that specializes in creating tools for the analysis and application of transactional data within the healthcare sector. Based in Cupertino, California, with additional offices in Washington, D.C., Chicago, Illinois, and Columbus, Ohio, the company offers a range of products, including the TransMed Suite, which provides an integrated platform for translational medicine. This suite supports the complete workflow from data aggregation to clinical application. Key offerings include the Adaptive Healthcare Unified Bioclinical system, which facilitates healthcare data management, the Clinically Actionable Report Engine that translates research discoveries into clinical practice, and the Bio-Informatics Suite that streamlines the translational research process. TransMed Systems' solutions are designed to empower health sciences researchers and clinicians by providing self-service access to aggregated bio-clinical data, enhancing their ability to conduct research and improve clinical practices. The company also maintains a strategic alliance with Pharmatech Inc.